Table 2 Senescent pathways and outcomes in cardiac, hepatic, and brain ischemia/reperfusion injury.
Organ | Model | Senescence pathway | Senescence outcomes | Ref. |
---|---|---|---|---|
Heart | C57BL/6J mice; LAD ischemia 60 min and reperfusion 24 h, 72 h, 1w, 4w | p16/pRb pathway P53/p21 pathway | Cardiac senescence ↑ (SA-β-gal ↑, SASP, p16INK4A ↑, p21CIP1 ↑) Cardiac function↓ | [56] |
Heart | C57BL/6J mice; Coronary artery ischemia 1d, 2d, 7d, 28d | p53/p21 pathway p16/pRb pathway | Cardiac senescence ↑ (SASP ↑, p53 ↑, p21 CIP1 ↑, p16 INK4A ↑) | [72] |
Heart | In vivo: C57BL/6J mice; LCA ischemia 45 min and reperfusion 24 h In vitro: Neonatal rat cardiomyocytes; Hypoxia 12 h and reoxygenation 24 h | p53/p21 pathway p16/pRb pathway | In vivo: Cardiac senescence ↑ (SA-β-gal ↑, SASP ↑, p16 INK4A ↑, p53 ↑, p19 ↑) Cardiac function↓ In vitro: Cardiac senescence ↑ (SA-β-gal ↑, SASP ↑, p16 INK4A ↑, p53 ↑, p19 ↑) | [123] |
Heart | In vivo: C57BL/6 mice; LAD ischemia 7d In vitro: Primary mice cardiomyocytes; H2O2 culture 24 h | p53/p21 pathway p16/pRb pathway | In vivo: Cardiac senescence ↑ (SASP ↑, p53 ↑, p16 INK4A ↑) Cardiac function↓ In vitro: Cardiac senescence ↑ (SA-β-gal ↑, p53 ↑, p16 INK4A ↑) | [143] |
Heart | In vivo: mice and rats; LAD ischemia 1w, 4w; In vitro: neonatal rat cardiomyocytes; hypoxia 16 h and reoxygenation 10 h | p53/p21 pathway | In vivo: Cardiac senescence ↑ (p53 ↑, SA-β-gal ↑) Cardiac function↓ Cardiac fibrosis↑ In vitro: Cardiac senescence ↑ (SA-β-gal ↑, p53 ↑) | [43] |
Heart | C57BL/6 mice; LAD ischemia 1d, 1w, 2w, 4w | p53/p21 pathway p16/pRb pathway | Cardiac senescence ↑ (SA-β-gal ↑, SASP ↑, p16 INK4A ↑, p53↑ and p21CIP1 ↑) | [98] |
Heart | C57BL/6N mice; TAC 2w, 6 w | p53/p21 pathway p16/pRb pathway | Cardiac senescence ↑ (SA-β-gal ↑, p16 INK4A ↑, p21CIP1 ↑) | [144] |
Liver | In vivo: C57/B6 mice; Partial hepatectomy, ischemia 1 h and reperfusion 6 h, 1d, 3d, 5d In vitro: hiPSC-MSCs cell line H2O2 culture 2 h and normal medium culture 48 h | p16/pRb pathway | In vivo: Hepatic senescence ↑ (SA-β-gal ↑, p16 INK4A ↑) Hepatic function↓ In vitro: Hepatic senescence ↑ (SA-β-gal ↑, p16 INK4A ↑) | [57] |
Brain | Adult male Wistar rats tMCAO ischemia 1 h and reperfusion 24 h, 3 and 7 d | p53/p21 pathway p16/pRb pathway | In vitro: Cerebral senescence ↑ (lipofuscin granules ↑, SASP ↑, p16 INK4A ↑, p53↑ and p21CIP1 ↑) | [99] |
Brain | In vivo: Male Sprague–Dawley rats; left MCAO ischemia 1 h and reperfusion 4d In vitro: Rat brain cortex astrocytes Oxygen-Glucose Deprivation 4 h and Reoxygenation 20 h | p16/pRb pathway | In vivo: Cerebral senescence ↑ (SASP ↑, p16 INK4A ↑) Inflammation ↑ (NOS2 ↑, MPO ↑) neurological functions↓ In vitro: Cerebral senescence ↑ (SA-β-gal ↑) | [102] |
Brain | In vivo: CD1 male mices; tMCAO ischemia 1 h and reperfusion 30 min and 72 h | p53/p21 pathway p16/pRb pathway | Cerebral senescence ↑ (p16 ↑, p21 ↑) Inflammation ↑ (TNFɑ↑, IL6 ↑, Cxcl1 ↑) | [100] |